The rate of a platelet response in the romiplostim group was 2.3 times that in the standard-of-care group (95% confidence interval [CI], 2.0 to 2.6; P<0.001). Patients receiving romiplostim had a ...

Romiplostim’s approval was based on the results of a phase-3 trial published in 2008 in The Lancet. The trial included two parallel studies; one enrolled splenectomized patients, and the other ...

Study of Unilateral Retinoblastoma With and Without Histopathologic High-Risk Features and the Role of Adjuvant Chemotherapy: A Children’s Oncology Group Study We conducted a phase II randomized trial ...

Nplate improved platelet response and reduced therapy modification for patients with chemotherapy-induced thrombocytopaenia.

June 12, 2009 (Berlin, Germany) — The platelet-stimulating drug romiplostim (Nplate) prevents a significant number of splenectomies in patients with immune thrombocytopenia (ITP), according to ...

Amgen Inc. (NASDAQ:AMGN)’s thrombocytopenia drug Nplate (romiplostim) showed significant benefits in a Phase III trial for ...

Newer second-generation thrombopoietin analogs, romiplostim (NPlate, Amgen) and eltrombopag (Promacta/Revolade, GlaxoSmithKline), have been developed. These agents stimulate the thrombopoietin ...

November 17, 2010 — Romiplostim may be more effective than standard of care for patients with immune thrombocytopenia (ITP), according to the results of an open-label, randomized study reported ...

The paper in the Nov. 11 New England Journal of Medicine reports that treatment with romiplostim, which mimics the effects of a growth factor that regulates platelet production, was more than ...

SAN DIEGO, CA—Long-term use of romiplostim in myelodysplastic syndrome (MDS) patients for up to 3.5 years (five years including therapy on prior studies) produced platelet responses in 83% of ...

Dublin, Dec. 30, 2020 (GLOBE NEWSWIRE) -- The "Nplate (Romiplostim) Romiplate - Drug Insight and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. Nplate ...

Amgen's Nplate proves highly effective in preventing thrombocytopenia from chemotherapy, enabling full-dose cancer treatment ...